Joseph G Schaefer

US Patent:

7355404, Apr 8, 2008

Filed:

Dec 13, 2005

Appl. No.:

11/275128

Inventors:

Hari Hariharan - Pewaukee WI, US
Joseph D. Schaefer - Waukesha WI, US

Assignee:

General Electric Company - Schenectady NY

International Classification:

G01V 3/00

US Classification:

324307

Abstract:

A method and apparatus for RF deposition prediction model refinement measures an RF parameter during a scan and refines the RF deposition prediction model by a correction factor based on the measured RF parameter.

US Patent:

20110034861, Feb 10, 2011

Filed:

Aug 7, 2009

Appl. No.:

12/537755

Inventors:

Joseph H. Schaefer - Grafton WI, US

International Classification:

A61F 13/00
A61M 1/00

US Classification:

604 23

Abstract:

A wound treatment apparatus that ventilates a wound dressing with warm humidified oxygen and/or air at a very low flow rate while under a sub-atmospheric pressure. A controlled flow of filtered air and/or oxygen is selected or blended under atmospheric pressure. This gas is pulled by a downstream vacuum source through a flow limiting device and exits at a sub-atmospheric pressure equal to the vacuum source. The gas flow is then humidified and heated to prescribed conditions before entering a substantially airtight negative pressure type wound dressing which is adapted for ventilation with an added inlet connection. This conditioned gas ventilates and nourishes the wound environment exiting the dressing outlet, through a fluid trap, to the vacuum source.

US Patent:

20120071813, Mar 22, 2012

Filed:

Nov 17, 2011

Appl. No.:

13/299184

Inventors:

Joseph H. Schaefer - Grafton WI, US

International Classification:

A61M 37/00
A61M 1/00

US Classification:

604 24

Abstract:

A method of treating a wound using condensation warming is disclosed. A wound dressing is applied over the wound in which the wound dressing has an inlet and an outlet and furthermore forms a substantially airtight cover over the wound. A vapor is supplied to the wound dressing via the inlet. The wound is warmed by condensing the vapor into a condensate on a surface of the wound, thereby releasing a latent heat of vaporization. The condensate is removed from the wound dressing via the outlet.

US Patent:

20130096516, Apr 18, 2013

Filed:

Dec 3, 2012

Appl. No.:

13/692617

Inventors:

Joseph H. Schaefer - Grafton WI, US

International Classification:

A61M 35/00

US Classification:

604290

Abstract:

A method of treating a wound by restoring a bodies' physiological norms is disclosed. A wound dressing is applied over the wound in which the wound dressing has an inlet and an outlet and furthermore forms a substantially airtight cover over the wound. A vapor is supplied to the wound dressing via the inlet. The wound is warmed by condensing the vapor into a condensate on a surface of the wound, thereby releasing a latent heat of vaporization and adding moisture to the wound. The excess condensate is removed from the wound dressing via the outlet.

US Patent:

53418417, Aug 30, 1994

Filed:

Oct 19, 1993

Appl. No.:

8/139244

Inventors:

Joseph H. Schaefer - Grafton WI

Assignee:

Acute Ideas, Inc. - Grafton WI

International Classification:

F15D 114

US Classification:

137561A

Abstract:

A fluid distribution device which can direct the flow of a fluid from a common source to a plurality of outlet ports wherein a distribution plate is sandwiched between members which serve as inlet and outlet ports. In a preferred manner, there is a flow restrictor in the distribution plate which is provided by passages extending through the plate. The members are symmetrical in configuration with one of the members providing as inlet port and both members providing outlet ports. This results in cost reduction. The fluid distribution device is particularly suitable for use with pneumatic control systems.

US Patent:

51781913, Jan 12, 1993

Filed:

Nov 15, 1991

Appl. No.:

7/795244

Inventors:

Joseph H. Schaefer - Grafton WI

Assignee:

Newmatic Controls Inc. - Grafton WI

International Classification:

F16K 1100

US Classification:

137884

Abstract:

A fluid module for a fluid control apparatus which has an internal fluid operated diaphragm which will permit the manifolding of several modules together. Each of the modules is of the same configuration and is interconnected to a common main fluid supply source. The modular units are plugged together using couplings with the main fluid source piped only to one device with an internal fluid passage delivering the fluid to all of the modular units. The modular units can be connected in a series or parallel combination with respect to signalling fluids. The modular units eliminate the cost of interconnecting different units at a variety of locations with different couplings as well as independently supplying each unit with a supply fluid.

US Patent:

20170296378, Oct 19, 2017

Filed:

Apr 15, 2016

Appl. No.:

15/099888

Inventors:

Joseph H. Schaefer - Grafton WI, US

International Classification:

A61F 7/00
G05B 15/02
F24F 11/00
A61F 7/00
A61F 7/00

Abstract:

The purpose of the disclosed thermostat is to prevent age-related diseases, induced by long term cool indoor temperatures. As people age, the body produces progressively less heat while aging-impaired vasoconstriction results in progressively more heat being lost. This age-induced cold stress requires ever greater use of vasoconstriction or behavior to maintain the body's heat balance. When behavioral regulation becomes diminished with age, vasoconstriction becomes progressive throughout life. In at risk elderly, an ongoing mild indoor cold stress can unknowingly maximize negative feedback vasoconstriction leaving it unable to further defend core body temperature. Before hypothermia occurs, positive feedback vasoconstriction activates as a defense mechanism. Like inflammation and fever, this beneficial defense mechanism can also cause harm when its use becomes excessive. The therapeutic function of this medical device is to sense skin temperature and use it to modify the indoor environment, keeping thermoregulation within the effective range of negative feedback vasoconstriction.